Simulations Plus Inc Q2 2026 Earnings: Beat on EPS and Revenue

Simulations Plus Inc (SLP) delivered a strong earnings beat for Q2 2026, reporting $0.35 EPS versus the $0.20 consensus estimate, representing a 75.44% surprise to the upside.

The company’s earnings per share of $0.35 significantly exceeded Wall Street expectations by $0.15, marking one of the largest positive surprises in recent quarters for the simulation software provider.

Revenue for the quarter reached $24.29 million, surpassing analyst estimates of $21.88 million by 11.01%. The $2.41 million revenue beat demonstrates solid demand for the company’s pharmaceutical modeling and simulation solutions.

The $24.29 million in quarterly revenue represents the company’s performance across its core biosimulation software and consulting services divisions during the three-month period ended in Q2 2026.

Both the 75.44% EPS surprise and 11.01% revenue surprise indicate stronger-than-expected execution by Simulations Plus management during the quarter, with the EPS beat being particularly notable given the significant margin by which actual results exceeded consensus forecasts.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.